Where Will Rocket Lab Stock Be in 1 Year?

Rocket Lab reported roughly $554 million revenue over the last 12 months with backlog rising to over $500 million (up 56% YoY), but is burning significant cash (approximately $232 million free cash burn LTM) as it funds development of the larger Neutron rocket, whose first test flight has been delayed to 2026. The Neutron, if successful, could materially expand revenue potential versus the smaller Electron, but the stock currently trades at a $39 billion market cap (P/S ~67), leaving valuation stretched and creating downside risk if commercial Neutron launches are further delayed or fail to drive profitability.

Analysis

Market structure: Rocket Lab (RKLB) sits at the nexus of small-launch demand and emerging medium-launch competition; near-term winners are incumbents with proven heavy‑lift economics (SpaceX private, incumbents capturing RFPs) and suppliers of satellite buses/solar arrays that can monetize existing backlog. RKLB’s 56% YoY backlog growth (> $500M) signals strong demand for launches, but a $39B market cap and P/S ~67 price the Neutron as binary optionality rather than cash‑flow reality, compressing pricing power for other niche small‑launch players if Neutron under‑delivers. Cross‑asset: failure or funding stress would lift equity volatility, widen high‑yield spreads and push risk‑off flows into USD and Treasuries; rocket propellant/metal inputs are immaterial to macro commodities but supplier equities (composites, avionics) will trade on order cadence.

Risk assessment: Tail risks include (1) Neutron test failure or multi‑year delay causing >50% revenue miss vs management guide, (2) regulatory/ITAR constraints limiting international customers, and (3) capital markets shock raising financing costs and forcing dilutive equity raises. Immediate (days) risk is event volatility around guidance/earnings; short term (3–12 months) hinge on cash burn (~$232M LTM) and funding runway; long term (2–5 years) depends on Neutron proving repeatable economics versus SpaceX. Hidden dependencies: customer concentration, supplier lead times for engines/composites, and booking-to-revenue conversion rate of the backlog (may be front‑loaded equipment/tech revenue vs recurring launch fees). Key catalysts: Neutron test (now pushed into 2026), SpaceX IPO timing, quarterly burn and new contract announcements.

Trade implications: Direct: initiate a tactical short of RKLB sized 1–3% of portfolio risk via a 6–9 month put spread (buy 30% OTM put, sell 50% OTM) to cap cost; alternatively a 12–18 month long‑dated short via buying 18‑month put LEAPs if available. Pair: short RKLB / go long RTX or LHX dollar‑neutral (1:1 notional) to capture asymmetric downside in speculative launch vs stable prime defense aerospace revenue. Options: sell near‑term covered call if long RKLB to harvest premium until Neutron proof; buy small 24‑36 month call LEAPs (1% portfolio) as binary upside lottery. Rotate out of speculative small‑cap space names into defense primes and satellite services (IRDM, MAXR) over next 3–12 months.

Contrarian angles: Consensus prices perfection into RKLB; what's missing is backlog convertibility—> quantify: if only 30–50% of backlog monetizes in 12 months, implied revenues fall sharply versus current valuation. Reaction is biased toward overvaluation rather than panic; a small, funded successful Neutron demonstration could spike shares >>100% (binary tail), so asymmetric option structures (buy cheap long‑dated calls 0.5–1% portfolio) are justified. Historical parallels: early launch winners (SpaceX) captured market after proving reusability; losers (Virgin Orbit) show capital intensity risk. Unintended consequence: retail-driven short squeezes are possible—manage position size and liquidity accordingly.

Key Decisions for Investors

• Establish a 2% portfolio short exposure to RKLB via a 6–9 month put spread: buy 30% OTM puts and sell 50% OTM puts to limit cost; add to size if Neutron test slips beyond Q4‑2026 or quarterly cash burn remains >$50M/month.
• Initiate a dollar‑neutral pair trade: short RKLB equal notional long RTX (RTX) or LHX (L3Harris) for 3–12 months to rotate speculative launch beta into defensive aerospace cashflow; rebalance if RKLB moves >25% intraday.
• Buy a small asymmetric upside ticket: allocate 0.5–1% portfolio to 18–36 month RKLB call LEAPs (or call spreads) keyed to a successful Neutron test, capped loss if the IPO/SpaceX catalyst re‑rates the sector.
• Reduce exposure to small‑cap space names by 30–50% over the next 3 months and redeploy into satellite services/operators (e.g., IRDM, MAXR) or primes (RTX, LHX) until Neutron proves repeatable economics or RKLB trades below a P/S of 20.
• Monitor three triggers in the next 90–180 days before scaling positions: (1) quarterly cash burn >$60M/month, (2) backlog monetization rate <40% of bookings in next 12 months, (3) official Neutron test date slipping further into 2027—each should increase short/add size thresholds.